Carbidopa: all 57 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's DiseaseRecruitingNCT06236230Phase 4
- Dopamine Modulation of Motivation and Motor Function in Major Depression & InflammationRecruitingNCT05909267Not applicable
- Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label ArmCompletedNCT06587217Phase 1/2Results posted
- Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled ArmCompletedNCT06219915Phase 1/2Results posted
- Neurobiological Drivers of Mobility Resilience: The Dopaminergic SystemCompletedNCT04325503Phase 1/2Results posted
- Norepinephrine-targeted Therapy for Action Control in Parkinson DiseaseCompletedNCT03115827Phase 4Results posted
- Inflammation-related Alterations in Neurocircuitry: Reversal With LevodopaCompletedNCT02513485Phase 4Results posted
- A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCompletedNCT01960842Phase 3Results posted
- A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's DiseaseCompletedNCT01736176Phase 3Results posted
- Vision Response to Dopamine ReplacementTerminatedNCT01663935Phase 2Results posted
- A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067CompletedNCT01568034Phase 2Results posted
- Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/BenserazideCompletedNCT01533116Phase 1Results posted
- Study of BIA 9-1067 to Investigate Its Effect on Levodopa PharmacokineticCompletedNCT01519284Phase 1Results posted
- Augmenting Language Therapy for Aphasia: LevodopaCompletedNCT01429077Phase 2/3Results posted
- High and Low Dose Carbidopa Treatment of Parkinson's DiseaseCompletedNCT01399905Phase 2Results posted
- Cognitive Remediation for Cocaine DependenceCompletedNCT01393457Phase 2Results posted
- Carbidopa for the Treatment of Nausea and Vomiting in Familial DysautonomiaCompletedNCT01212484Phase 3Results posted
- Levodopa for the Treatment of Residual AmblyopiaCompletedNCT01190813Phase 3Results posted
- A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066CompletedNCT01130493Phase 3Results posted
- Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of CarbidopaCompletedNCT00983814Phase 2Results posted
- Study on Tolerability of Levodopa/Carbidopa in Children With Angelman SyndromeCompletedNCT00829439Phase 1Results posted
- Pilot Study to Evaluate Levodopa as Treatment for Residual AmblyopiaCompletedNCT00789672Phase 2Results posted
- Peripheral Dopamine in Postural Tachycardia SyndromeCompletedNCT00685919Phase 2/3Results posted
- Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing OffTerminatedNCT00642356Phase 4Results posted
- Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedNCT00547911Phase 1/2Results posted
- Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-offCompletedNCT00391898Phase 4Results posted
- Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsCompletedNCT00360568Phase 3Results posted
- Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseCompletedNCT00335153Phase 3Results posted
- Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's DiseaseCompletedNCT00219284Phase 4Results posted
- Medications for Stopping Cocaine Dependence and Preventing RelapseCompletedNCT00218023Phase 2Results posted
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa TherapyCompletedNCT00099268Phase 3Results posted
- A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy SubjectsCompletedNCT06161220Phase 1
- Histaminergic Basis of Fatigue in Multiple SclerosisWithdrawnNCT04764383Phase 2
- Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain PlasticityWithdrawnNCT04082715Phase 2
- Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EESCompletedNCT04052776Phase 1
- Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel ApproachCompletedNCT03266965Phase 1
- Studying a Potential Protective Effect of L-Dopa on Retinitis PigmentosaStatus unknownNCT02837640Phase 2
- Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke RehabilitationWithdrawnNCT02346630Phase 4
- Remission of ICD by Switching Dopamine Agonist to Levodopa/CarbidopaCompletedNCT01683253Phase 4
- Antipsychotic Augmentation With L-DopaCompletedNCT01636037Phase 2
- A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's DiseaseCompletedNCT01484990Phase 1
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)CompletedNCT01437293Phase 1
- Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With FibromyalgiaCompletedNCT01323374Phase 2
- Comparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensCompletedNCT01296464Phase 2
- Dopaminergic Modulation of Cognition and Psychomotor FunctionCompletedNCT01218425Not applicable
- An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease SubjectsCompletedNCT00914602Phase 1/2
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) InhibitorsCompletedNCT00906828Phase 4
- Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa PharmacokineticsCompletedNCT00888186Phase 4
- Pharmacokinetic Study With Repeated Doses of StalevoCompletedNCT00693862Phase 1
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing OffWithdrawnNCT00601978Phase 4
- Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's DiseaseCompletedNCT00558337Phase 2
- Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic NeuropathyCompletedNCT00432393Phase 4
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine DependenceCompletedNCT00218075Phase 2
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)CompletedNCT00200447Phase 2
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United StatesCompletedNCT00143026Phase 4
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaCompletedNCT00134966Phase 3